These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28493004)

  • 1. Efavirenz Dissolution Enhancement IV-Antisolvent Nanocrystallization by Sonication, Physical Stability, and Dissolution.
    Sartori GJ; Prado LD; Rocha HVA
    AAPS PharmSciTech; 2017 Nov; 18(8):3011-3020. PubMed ID: 28493004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation.
    Patel GV; Patel VB; Pathak A; Rajput SJ
    Drug Dev Ind Pharm; 2014 Jan; 40(1):80-91. PubMed ID: 23323843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
    J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efavirenz dissolution enhancement III: Colloid milling, pharmacokinetics and electronic tongue evaluation.
    Hoffmeister CR; Fandaruff C; da Costa MA; Cabral LM; Pitta LR; Bilatto SE; Prado LD; Corrêa DS; Tasso L; Silva MA; Rocha HV
    Eur J Pharm Sci; 2017 Mar; 99():310-317. PubMed ID: 28042101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam.
    Ambrus R; Kocbek P; Kristl J; Sibanc R; Rajkó R; Szabó-Révész P
    Int J Pharm; 2009 Nov; 381(2):153-9. PubMed ID: 19616609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement.
    Gera S; Talluri S; Rangaraj N; Sampathi S
    AAPS PharmSciTech; 2017 Nov; 18(8):3151-3162. PubMed ID: 28534300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
    Ige PP; Baria RK; Gattani SG
    Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation.
    Alshweiat A; Katona G; Csóka I; Ambrus R
    Eur J Pharm Sci; 2018 Sep; 122():94-104. PubMed ID: 29908301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
    Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocrystallization by evaporative antisolvent technique for solubility and bioavailability enhancement of telmisartan.
    Bajaj A; Rao MR; Pardeshi A; Sali D
    AAPS PharmSciTech; 2012 Dec; 13(4):1331-40. PubMed ID: 23054986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubility and dissolution performances of spray-dried solid dispersion of Efavirenz in Soluplus.
    Lavra ZM; Pereira de Santana D; Ré MI
    Drug Dev Ind Pharm; 2017 Jan; 43(1):42-54. PubMed ID: 27349377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevancy of controlled nanocrystallization on rifampicin characteristics and cytotoxicity.
    Mohyeldin SM; Mehanna MM; Elgindy NA
    Int J Nanomedicine; 2016; 11():2209-22. PubMed ID: 27274244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugation of Hot-Melt Extrusion with High-Pressure Homogenization: a Novel Method of Continuously Preparing Nanocrystal Solid Dispersions.
    Ye X; Patil H; Feng X; Tiwari RV; Lu J; Gryczke A; Kolter K; Langley N; Majumdar S; Neupane D; Mishra SR; Repka MA
    AAPS PharmSciTech; 2016 Feb; 17(1):78-88. PubMed ID: 26283197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
    Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X
    Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical activation of Efavirenz: the effects on the dissolution and inhibitory behavior.
    Cappelletto E; Firrito C; Pizzato M; Rebuffi L; Scardi P
    Pharm Dev Technol; 2018 Dec; 23(10):1128-1135. PubMed ID: 29688125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design.
    Kassem MAA; ElMeshad AN; Fares AR
    AAPS PharmSciTech; 2017 May; 18(4):983-996. PubMed ID: 27506564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and optimization of efavirenz nanosuspensions using the precipitation-ultrasonication technique for solubility enhancement.
    Taneja S; Shilpi S; Khatri K
    Artif Cells Nanomed Biotechnol; 2016 May; 44(3):978-84. PubMed ID: 25724312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid dispersion of efavirenz in PVP K-30 by conventional solvent and kneading methods.
    Alves LD; de La Roca Soares MF; de Albuquerque CT; da Silva ER; Vieira AC; Fontes DA; Figueirêdo CB; Soares Sobrinho JL; Rolim Neto PJ
    Carbohydr Polym; 2014 Apr; 104():166-74. PubMed ID: 24607174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
    Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
    Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.